These results suggest that IFITM1 is closely involved in MPNST pathogenesis and that IFN-γ can effectively suppress the progression of benign PN tumor to MPNST in NF1 through IFITM1 induction and subsequent negative regulation of the Ras/ERK signaling pathway. The gene discussed is IFNG; the disease is malignant peripheral nerve sheath tumor.